Anxiety Disorders And Depression Treatment Market Size And Share

Report Code : TIPRE00008009
Category : Life Sciences

No. of Pages : 150

Buy Now

Analyse des parts de marché et des principaux résultats du traitement des troubles anxieux et de la dépression d'ici 2025-2031

Buy Now

Anxiety Disorders and Depression Treatment Market Report Analysis

Anxiety Disorders and Depression Treatment Market

CAGR (2023 - 2031)
XX%
Market Size 2023
US$ XX million
Market Size 2031
US$ XX Million

Report Coverage

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis

Industry landscape and competition analysis & recent developments
Detailed company profiles

Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

Sumitomo Dainippon Pharma Co.
Sage Therapeutics
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Abbott
Sanofi
H. Lundbeck A/S

Regional Overview

Amérique du Nord
Europe
Asie-Pacifique
Amérique du Sud et centrale
Moyen-Orient et Afrique

Market Segmentation

By Classe de médicaments [inhibiteurs sélectifs de la recapture de la sérotonine

ISRS
antidépresseurs tricycliques

By Thérapies [électroconvulsivothérapie

ECT
psychothérapie
stimulation cérébrale profonde
thérapie cognitivo-comportementale

By Appareils

stimulateur d'électrothérapie crânienne
stimulateur Fisher-Wallace

By Application

phobie
trouble obsessionnel compulsif